• Latest Posts

Australian biopharma Telix banks on AI with Dedicaid acquisition

More News! 25 Apr 2023

More efficient and cost-effective mRNA vaccines developed

First toxic shock syndrome vaccine phase 2 study completed

Alcohol-related liver disease: mechanism could lead to new therapies

New biomarker for early prediction of response to CAR-T cell therapy

Partnership to deliver oncology workflow for 7 European hospitals

ADVERTISEMENT

Arecor to start second type 2 diabetes clinical trial

More News! 26 Oct 2022

Study shows ability to develop and apply targeted treatment in head and neck cancers

Skin microbiome research could lead to new approaches for addressing organ damage after stem cell transplants

New approaches beckon for small cell lung cancer treatment

New drug boosts options for rheumatoid arthritis treatment

From mugwort allergy to an effective vaccine?

ADVERTISEMENT